AL amyloidosis and a critical, early diagnosis
Do CLL patients with mutated immunoglobulin receptors respond better to therapy?
An overview of the current treatment landscape of non-Hodgkin lymphoma
Top follicular lymphoma discussion points at ICML 2017
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.